News

In the fight against Alzheimer's, Lion's mane mushroom shows promise. A recent study reveals that its extract can ease ...
Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.
Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for the treatment of neurotrophic keratitis (NK), a degenerative corneal disease ...
Members of the nerve growth factor (NGF) and glial cell line-derived neurotrophic factor (GDNF) families — comprising neurotrophins and GDNF-family ligands (GFLs), respectively — are crucial ...
PITTSBURGH, July 09, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) announced today that the first patient has been dosed in its Phase 1/2 clinical trial ("EMERALD-1”), ...
Eye drop administration of KB801 designed to enable sustained expression of NGF in the front of the eye Investor call and webcast to be held July 9 at 8:30 am ET to discuss program and trial design PI ...
According to NYU Langone, more than 80% of men and nearly half of women experience hair loss at some point in their lives. But with so much info out there, figuring out which remedies are most ...
Neuro Energizer reviews reveal my 30-day experience with this brain supplement—see real results, ingredients, benefits, ...
We are proud to announce the official launch of Brain Defender, our groundbreaking cognitive support formula designed to enhance mental clarity, focus, memory, and long-term brain health. Developed ...
A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.
Secreted growth factors bind to transmembrane growth factor receptors to stimulate cell signalling cascades that promote proliferation, apoptosis and differentiation.
The site of injection is the crucial factor in determining the degree of nerve fiber injury. The degree of injury varies significantly, depending upon the specific agent injected.